pyrroles has been researched along with Asthma in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 9 (25.00) | 18.2507 |
| 2000's | 7 (19.44) | 29.6817 |
| 2010's | 17 (47.22) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, L; Li, Q; Liu, Z; Zhang, G; Zhang, M; Zhang, X; Zhou, X; Zhu, L | 1 |
| Aguilar-Pimentel, A; Alessandrini, F; Blank, S; Chaker, A; Fuchs, H; Gailus-Durner, V; Graessel, A; Gutermuth, J; Hrabě de Angelis, M; Ollert, M; Russkamp, D; Schmidt-Weber, CB | 1 |
| Katial, RK; Kraft, M; Lugogo, NL; Que, LG; Rodman, DM; Shoemaker, SA; Tighe, RM; Troha, JM; Yang, Z | 1 |
| Addison, KJ; Ledford, JG; Myrdal, PB; Vallorz, E; Younis, US | 1 |
| Jackson, AE | 1 |
| Blonder, JP; Boyanapalli, R; Delany, C; Green, LH; Look, K; Looker, D; Mehra, NK; Mutka, SC; Qiu, J; Richards, JP; Rosenthal, GJ; Scoggin, C; Sun, X; Suniga, M | 1 |
| Alzina, S; De Alba, J; Esteve, C; González, J; Gual, S; Horrillo, R; Jover, I; Miralpeix, M; Sentellas, S; Tarrasón, G; Vidal, B; Vidal, L | 1 |
| Berhan, A; Harris, T; Keenan, CR; Langenbach, S; Royce, SG; Schuliga, M; Stewart, AG | 1 |
| Gupta, V; Lehner, MD; Miralpeix, M; Pearson, J; Plumb, J; Ramis, I; Singh, D; Southworth, T | 1 |
| Chaudhuri, R; Donnelly, I; Hothersall, EJ; Lafferty, J; McInnes, I; McMahon, AD; McSharry, C; Meiklejohn, J; Sattar, N; Thomson, NC; Weir, CJ; Wood, S | 1 |
| Chiba, J; Iigou, Y; Iimura, S; Machinaga, N; Muro, F; Nakayama, A; Setoguchi, M; Takashi, T; Takayama, G; Watanabe, T; Yokoyama, M; Yoneda, Y | 1 |
| DU, Q; Huang, M; Liu, X; Yao, X; Yin, KS | 1 |
| Furutani, M; Hondo, T; Hoshii, H; Kontani, T; Kuromitsu, S; Maeda, J; Moritomo, A; Nagashima, S; Nagata, H; Ogiyama, T; Ohga, K; Ohno, K; Ohta, M; Orita, M; Shiozuka, K; Takeuchi, M; Tsukamoto, S | 1 |
| Choi, EJ; Choi, JP; Gho, YS; Hong, SW; Jeon, SG; Kim, YK; Kim, YS; Moon, HG; Oh, SY; Shin, TS; Zhu, Z | 1 |
| Braganza, G; Chaudhuri, R; Donnelly, I; Jolly, L; Lafferty, J; Lloyd, SM; Mair, F; McSharry, C; Spears, M; Thomson, NC; Weir, CJ | 1 |
| Blonder, JP; Colagiovanni, DB; Green, LS; Mutka, SC; Qiu, J; Richards, JP; Rosenthal, GJ; Stout, AM; Strong, SA; Sun, X; Wasley, JW | 2 |
| Colagiovanni, DB; Drolet, DW; Langlois-Forget, E; Looker, D; Piché, MP; Rosenthal, GJ | 1 |
| Pettipher, R; Whittaker, M | 1 |
| Pabelick, CM; Prakash, YS; Sathish, V; Thompson, MA; Townsend, EA | 1 |
| Rosenberg, JL | 1 |
| Huang, CF; Lo, WT; Peng, HJ; Shih, YL; Wu, CC; Wu, TC | 1 |
| Fukui, H; Horio, S; Kawakami, N; Miyoshi, K | 1 |
| Lumry, WR; Pleskow, WW; Simon, RA | 1 |
| Botha, JJ; Weich, DJ | 1 |
| Imagawa, J; Kamei, K; Koga, T; Nabata, H; Sugo, I; Yoshida, S | 1 |
| Chapman, ID; Cook, NS | 1 |
| Alouan, LA; Armour, CL; Black, JL; Johnson, PR; Marthan, R; McKay, KO; Savineau, JP; Tunon de Lara, JM; Villanove, X | 1 |
| Barnes, PJ; Chung, KF; Fuller, RW; Kidney, JC; Lavender, EA; Worsdell, YM | 1 |
| Nielsen-Kudsk, JE | 1 |
| Ohbayashi, H | 1 |
| Berry, JL; Burka, JF; Cook, SJ; Foster, RW; Green, KA; Murray, MA; Small, RC | 1 |
| Aitken, S; De Jonckheere, B; McCaig, DJ | 1 |
| Goto, S; Kitagaki, K; Koda, A; Nagai, H; Suda, H | 1 |
| Chiew, F; Cochrane, GM; Hopkirk, A; Lavender, E; Lee, TH; Owen, S; Richards, DH; Stone, P; Vyse, T; Williams, AJ | 1 |
3 review(s) available for pyrroles and Asthma
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis.
Topics: Acetates; Animals; Asthma; Aza Compounds; Carbazoles; Clinical Trials as Topic; Humans; Indoleacetic Acids; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Immunologic; Receptors, Prostaglandin; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfonamides; Th2 Cells; Thiazoles | 2012 |
Potassium channel activators and bronchial asthma.
Topics: Animals; Asthma; Benzopyrans; Bronchodilator Agents; Cromakalim; Humans; In Vitro Techniques; Muscle, Smooth; Potassium Channels; Pyrroles; Synaptic Transmission | 1992 |
7 trial(s) available for pyrroles and Asthma
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Effect of the S-nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma.
Topics: Administration, Intravenous; Adult; Aldehyde Oxidoreductases; Asthma; Benzamides; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Placebos; Proof of Concept Study; Pyrroles; S-Nitrosoglutathione; Treatment Outcome; Young Adult | 2018 |
Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
Topics: Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Asthmatic Agents; Asthma; Atorvastatin; Biomarkers; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Sputum; Vital Capacity | 2008 |
Effects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial.
Topics: Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Atorvastatin; Beclomethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Forced Expiratory Volume; Heptanoic Acids; Humans; Male; Peak Expiratory Flow Rate; Pyrroles; Quality of Life; Smoking; Surveys and Questionnaires; Treatment Outcome | 2011 |
Estrogen effects on human airway smooth muscle involve cAMP and protein kinase A.
Topics: Adrenergic beta-Agonists; Asthma; Bronchoconstriction; Calcium Signaling; Carbazoles; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Estradiol; Estrogens; Female; Humans; Isoproterenol; Myocytes, Smooth Muscle; Pyrroles; Receptors, Adrenergic, beta; Respiratory System | 2012 |
Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol.
Topics: Adult; Asthma; Benzopyrans; Bronchodilator Agents; Cromakalim; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Methacholine Chloride; Middle Aged; Pyrroles; Time Factors; Vital Capacity | 1993 |
Attenuation of nocturnal asthma by cromakalim.
Topics: Adult; Analysis of Variance; Asthma; Benzopyrans; Bronchodilator Agents; Circadian Rhythm; Cromakalim; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Half-Life; Humans; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic | 1990 |
27 other study(ies) available for pyrroles and Asthma
| Article | Year |
|---|---|
Participation of Antidiuretic Hormone (ADH) in Asthma Exacerbations Induced by Psychological Stress via PKA/PKC Signal Pathway in Airway-Related Vagal Preganglionic Neurons (AVPNs).
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Asthma; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Cytokines; Disease Models, Animal; Eosinophils; Female; Mice; Mice, Inbred BALB C; Morpholines; Neurons; Ovalbumin; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Receptors, Vasopressin; Signal Transduction; Spiro Compounds; Stress, Psychological; Vasopressins | 2017 |
Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma.
Topics: Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Differentiation; Cytokines; Desensitization, Immunologic; Disease Models, Animal; Humans; Janus Kinases; Mice; Mice, Inbred C57BL; Ovalbumin; Piperidines; Pyrimidines; Pyrroles | 2017 |
Preformulation and Evaluation of Tofacitinib as a Therapeutic Treatment for Asthma.
Topics: Administration, Inhalation; Allergens; Animals; Anti-Asthmatic Agents; Asthma; Drug Compounding; Drug Stability; Female; Mice; Mice, Inbred BALB C; Piperidines; Pyrimidines; Pyroglyphidae; Pyrroles | 2019 |
In this issue - May 2019: West Nile virus in horses · Treating horses with dexamethasone via nebulisation · Animal hoarding in NSW · Dangers of powdered washing soda for emesis in dogs · Pneumocystis in a dog following toceranib phosphate · Oxalate nephro
Topics: Animals; Anti-Inflammatory Agents; Asthma; Dexamethasone; Dog Diseases; Dogs; Emetics; Hoarding; Horse Diseases; Horses; Indoles; Nebulizers and Vaporizers; Nephrosis; New South Wales; Oxalates; Phascolarctidae; Pneumocystis; Pneumocystis Infections; Powders; Pyrroles; Vomiting; West Nile Fever; West Nile virus | 2019 |
Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.
Topics: Aldehyde Oxidoreductases; Animals; Asthma; Benzamides; Bronchoconstriction; Female; Inflammation; Mice; Mice, Inbred BALB C; Pyrroles | 2014 |
Discovery of 7-azaindole derivatives as potent Orai inhibitors showing efficacy in a preclinical model of asthma.
Topics: Animals; Asthma; Aza Compounds; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Drug Evaluation, Preclinical; Half-Life; Humans; Hypersensitivity; Indoles; Interleukin-2; Jurkat Cells; Microsomes; Models, Biological; Ovalbumin; Protein Binding; Pyridines; Pyrroles; Rats; Structure-Activity Relationship | 2015 |
The Coagulant Factor Xa Induces Protease-Activated Receptor-1 and Annexin A2-Dependent Airway Smooth Muscle Cytokine Production and Cell Proliferation.
Topics: Airway Remodeling; Annexin A2; Asthma; Biopsy; Cell Proliferation; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Factor Xa; Gene Expression Regulation; Humans; Integrin beta1; Myocytes, Smooth Muscle; Pyrroles; Quinazolines; Receptor, PAR-1; Respiratory System; RNA Interference; RNA, Messenger; Signal Transduction; Thrombin; Time Factors; Transfection | 2016 |
Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients.
Topics: Adult; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Case-Control Studies; CD3 Complex; Cells, Cultured; Class I Phosphatidylinositol 3-Kinases; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Inflammation Mediators; Interferon-gamma; Interleukin-13; Interleukin-17; Janus Kinase Inhibitors; Janus Kinases; Lung; Lymphocyte Activation; Male; Middle Aged; Molecular Targeted Therapy; Piperidines; Pyrimidines; Pyrroles; Signal Transduction; T-Lymphocytes | 2016 |
Identification of 4-[1-[3-chloro-4-[N'-(5-fluoro-2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Asthma; Benzoates; Cells, Cultured; Disease Models, Animal; Dogs; Female; Inhibitory Concentration 50; Integrin alpha4beta1; Mice; Mice, Inbred BALB C; Permeability; Pyrroles; Rats | 2008 |
Inhibitory effects of sunitinib on ovalbumin-induced chronic experimental asthma in mice.
Topics: Angiogenesis Inhibitors; Animals; Asthma; Blotting, Western; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Female; Immunoglobulin E; Immunohistochemistry; Immunoprecipitation; In Vitro Techniques; Indoles; Inflammation; Interleukin-13; Interleukin-4; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Proto-Oncogene Proteins c-kit; Pyrroles; Sunitinib | 2009 |
Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitors.
Topics: Administration, Oral; Animals; Asthma; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Eosinophils; Humans; Immunity; Mice; Pyrimidines; Pyrroles; STAT6 Transcription Factor; Structure-Activity Relationship; Th2 Cells | 2009 |
Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways.
Topics: Allergens; Animals; Apoptosis; Asthma; Immunity, Active; Immunity, Innate; Indoles; Inflammation; Interleukin-12; Interleukin-17; Interleukin-6; Lipopolysaccharides; Lung; Mice; Mice, Inbred BALB C; Mice, Knockout; Ovalbumin; Protein Kinase Inhibitors; Pyrroles; T-Lymphocytes, Helper-Inducer; Th1 Cells; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities.
Topics: Aldehyde Oxidoreductases; Animals; Asthma; Benzamides; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Imidazoles; Lung; Mice; Molecular Structure; Molecular Targeted Therapy; No-Observed-Adverse-Effect Level; Pyrroles; Receptors, Opioid, delta; S-Nitrosoglutathione; Structure-Activity Relationship | 2011 |
A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma.
Topics: Alanine Transaminase; Aldehyde Oxidoreductases; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Asthma; Benzamides; Bile; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Enzyme Inhibitors; Feces; Female; Glutathione; Liver; Lung; Male; Pyrroles; Rats; Rats, Sprague-Dawley | 2012 |
Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.
Topics: Acute Disease; Aldehyde Oxidoreductases; Animals; Anti-Asthmatic Agents; Asthma; Benzamides; Enzyme Inhibitors; Humans; Male; Mice; Ovalbumin; Pyrroles; S-Nitrosoglutathione; S-Nitrosothiols; Structure-Activity Relationship | 2012 |
Antilipid agents may provide allergy protection.
Topics: Animals; Asthma; Atorvastatin; Bronchial Hyperreactivity; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypersensitivity; Pravastatin; Pyrroles | 2013 |
Effect of oral administration with pravastatin and atorvastatin on airway hyperresponsiveness and allergic reactions in asthmatic mice.
Topics: Administration, Oral; Animals; Asthma; Atorvastatin; Bronchial Hyperreactivity; Cytokines; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypersensitivity; Immunoglobulin G; Mice; Mice, Inbred BALB C; Ovalbumin; Pravastatin; Pyrroles; Rats, Sprague-Dawley; Th1 Cells | 2013 |
Beta(2)-adrenergic receptor-mediated histamine H(1) receptor down-regulation: another possible advantage of beta(2) agonists in asthmatic therapy.
Topics: Adrenergic beta-Agonists; Animals; Asthma; Bronchodilator Agents; Carbazoles; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Enzyme Inhibitors; Histamine H1 Antagonists; Humans; Indoles; Isoproterenol; Phosphorylation; Pyrilamine; Pyrroles; Receptors, Adrenergic, beta-2; Receptors, Histamine H1 | 2004 |
Zomepirac sodium (Zomax) hypersensitivity in aspirin-sensitive asthmatics.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Asthma; Drug Hypersensitivity; Female; Forced Expiratory Volume; Humans; Middle Aged; Pyrroles; Tolmetin | 1984 |
Hypersensitivity to non-steroidal anti-inflammatory drugs--asthma precipitated by zomepirac. A case report.
Topics: Analgesics; Aspirin; Asthma; Humans; Male; Middle Aged; Pyrroles; Time Factors; Tolmetin | 1984 |
In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
Topics: Administration, Inhalation; Albuterol; Anesthesia; Animals; Antigens; Asthma; Benzopyrans; Bronchoconstriction; Bronchodilator Agents; Consciousness; Cromakalim; Disease Models, Animal; Guinea Pigs; Histamine; Immunization; Injections, Intravenous; Male; Potassium Channels; Pyrroles | 1994 |
Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma.
Topics: Animals; Asthma; Benzopyrans; Cromakalim; Cyclopentanes; Disease Models, Animal; Humans; Parasympatholytics; Peripheral Vascular Diseases; Potassium Channels; Pyrroles; Rats | 1993 |
Sensitization decreases relaxation in human isolated airways.
Topics: Asthma; Benzopyrans; Bronchi; Bucladesine; Carbachol; Colforsin; Cromakalim; Dose-Response Relationship, Drug; Humans; Immunization, Passive; Immunoglobulin E; In Vitro Techniques; Isoproterenol; Muscle Relaxation; Muscle Tonus; Parasympatholytics; Pyrroles; Verapamil | 1993 |
Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Topics: Animals; Arteries; Asthma; Benzopyrans; Bronchi; Cardiovascular Diseases; Cromakalim; Female; Guinea Pigs; Humans; Male; Membrane Potentials; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Potassium Channels; Pyrroles; Sulfonylurea Compounds; Synaptic Transmission; Trachea; Vasodilator Agents | 1996 |
ZD-0892 AstraZeneca.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Drugs, Investigational; Enzyme Inhibitors; Humans; Leukocyte Elastase; Pyrroles; Structure-Activity Relationship; Sulfonamides | 2000 |
Comparison of the effects of cromakalim in trachea isolated from normal and albumin-sensitive guinea-pigs.
Topics: Acetylcholine; Albumins; Animals; Asthma; Benzopyrans; Bronchodilator Agents; Cromakalim; Disease Models, Animal; Electric Stimulation; Flurbiprofen; Guinea Pigs; Immunization; In Vitro Techniques; Male; Potassium Channels; Pyrroles; Trachea | 1992 |
Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
Topics: Airway Resistance; Animals; Asthma; Benzopyrans; Bronchodilator Agents; Cromakalim; Guanidines; Guinea Pigs; In Vitro Techniques; Mice; Mice, Inbred Strains; Niacinamide; Nicorandil; Passive Cutaneous Anaphylaxis; Pinacidil; Potassium Channels; Pyrroles; Rats; Trachea; Vasculitis | 1991 |